New generations of dihydropyridines for treatment of hypertension.

Article Details

Citation
Copy to clipboard

Wang AL, Iadecola C, Wang G

New generations of dihydropyridines for treatment of hypertension.

J Geriatr Cardiol. 2017 Jan;14(1):67-72. doi: 10.11909/j.issn.1671-5411.2017.01.006.

PubMed ID
28270844 [ View in PubMed
]
Abstract

Since the calcium channel blocker (CCB) has become one of the most prescribed agents for antihypertensive monotherapy in the world, this brief review will focus on the recent research and development of the dihydropyridine (DHP) CCB, addressing pharmacological mechanisms for the clinical efficacy of the third and fourth generations of the DHP CCBs, especially on their possible central mechanisms underlying lowering blood pressure.

DrugBank Data that Cites this Article

Drugs